Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 09939 KINTOR PHARMA-B > Detailed Quotes

09939 KINTOR PHARMA-B

11.140
-0.240-2.11%
Market Close 09/30 16:08 CCT
High
11.600
Open
11.600
Turnover
38.53M
Low
10.460
Pre Close
11.380
Volume
3.53M
Market Cap
4.54B
P/E(TTM)
Loss
52wk High
64.000
Shares
407.50M
P/E(Static)
Loss
52wk Low
6.910
Float Cap
4.54B
Bid/Ask %
-70.15%
Historical High
89.000
Shs Float
407.50M
Volume Ratio
0.36
Historical Low
6.910
Dividend TTM
--
Div Yield TTM
--
P/B
3.27
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.87%
Amplitude
10.02%
Avg Price
10.918
Lot Size
500
Float Cap
4.54B
Bid/Ask %
-70.15%
Historical High
89.000
Shs Float
407.50M
Volume Ratio
0.36
Historical Low
6.910
Dividend TTM
--
P/B
3.27
Dividend LFY
--
Turnover Ratio
0.87%
Amplitude
10.02%
Avg Price
10.918
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Pioneering Pharmaceutical Co., Ltd. is a new drug developer in the clinical stage, focusing on cancer drugs and other androgen receptor (AR)-related diseases. The company's main drug under research is Proclomide. The drug is in phase III clinical trials of metastatic castration-resistant prostate cancer (mCRPC) in China. The company's clinical drug under development also includes an II phase small molecule development drug Pyrilutamide, an II phase monoclonal antibody development drug ALK-1, a phase I mTOR inhibitor Detorsertib, and an hedgehog signal transduction pathway inhibitor GT1708F.
CEO: Youzhi Tong
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...